<SEC-DOCUMENT>0001144204-17-007063-index.html : 20170209
<SEC-HEADER>0001144204-17-007063.hdr.sgml : 20170209
<ACCEPTANCE-DATETIME>20170209161536
ACCESSION NUMBER:		0001144204-17-007063
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20170209
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170209
DATE AS OF CHANGE:		20170209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Moleculin Biotech, Inc.
		CENTRAL INDEX KEY:			0001659617
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				474671999
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37758
		FILM NUMBER:		17587753

	BUSINESS ADDRESS:	
		STREET 1:		2575 WEST BELLFORT
		STREET 2:		SUITE 333
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77054
		BUSINESS PHONE:		713-300-5160

	MAIL ADDRESS:	
		STREET 1:		2575 WEST BELLFORT
		STREET 2:		SUITE 333
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77054
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v458901_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: v458901_8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>v458901_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
Document 2 - file: v458901_ex1-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>v458901_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
Document 3 - file: v458901_ex4-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>v458901_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 4 - file: v458901_ex99-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>pg1img1_ex99-1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: pg1img1_ex99-1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>pg2img1_ex99-1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: pg2img1_ex99-1.jpg

</DOCUMENT>
</SEC-DOCUMENT>